Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study.
Schoemaker, Nadja E
Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study. [electronic resource] - Anti-cancer drugs Jan 2002 - 87-91 p. digital
Publication Type: Journal Article
0959-4973
10.1097/00001813-200201000-00010 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers--blood
Cisplatin--administration & dosage
DNA Topoisomerases, Type I--metabolism
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Leukocytes--enzymology
Middle Aged
Ovarian Neoplasms--blood
Paclitaxel--administration & dosage
Topotecan--administration & dosage
Tumor Cells, Cultured--drug effects
Topoisomerase I levels in white blood cells of patients with ovarian cancer treated with paclitaxel-cisplatin-topotecan in a phase I study. [electronic resource] - Anti-cancer drugs Jan 2002 - 87-91 p. digital
Publication Type: Journal Article
0959-4973
10.1097/00001813-200201000-00010 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers--blood
Cisplatin--administration & dosage
DNA Topoisomerases, Type I--metabolism
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Leukocytes--enzymology
Middle Aged
Ovarian Neoplasms--blood
Paclitaxel--administration & dosage
Topotecan--administration & dosage
Tumor Cells, Cultured--drug effects